| Product Code: ETC089509 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Antiparasitics Drugs Market was estimated at USD 281 Million in 2025 and is projected to reach USD 396 Million by 2032, growing at a CAGR of 5.0% from 2026 to 2032. This growth trajectory is significantly driven by the high prevalence of parasitic infections in the country, coupled with increased public awareness and government initiatives aimed at disease prevention. As the healthcare landscape evolves, innovation in drug development further positions the market for sustained expansion.
This graph highlights how the Vietnam Antiparasitics Drugs Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.1% | Foreign direct investments boosted Vietnam’s pharmaceutical manufacturing capacity |
| 2022 | 2.9% | Investment in biotechnology elevates antiparasitic drug production capabilities |
| 2023 | 8.1% | Increased export demand boosts domestic antiparasitic drug production capacity |
| 2024 | 5.5% | Technological upgrades in production lines boost antiparasitics manufacturing efficiency |
| 2025 | 6.4% | Increased demand for antiparasitic drugs drives local manufacturing investment |
| 2026 | 7.7% | Increased export demand boosts local antiparasitics manufacturing capacity |
| 2027 | 7.5% | Technology integration in pharmaceutical manufacturing enhances antiparasitic drug efficiency |
| 2028 | 6.1% | New partnerships enhance capacity for antiparasitic drug exports |
| 2029 | 6.4% | Increased foreign investment boosts local production of antiparasitics |
| 2030 | 6.0% | Foreign investments boost local production capacity for antiparasitics |
| 2031 | 5.5% | Foreign investments boosted capacity for antiparasitic drug production |
| 2032 | 5.8% | Higher domestic consumption of antiparasitics boosts pharmaceutical manufacturing capacity |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In Vietnam, the demand for antiparasitic drugs has surged due to the country's favorable climate, which facilitates the growth of various parasites. This has resulted in a persistent need for effective treatments to combat these infections, influencing the market's dynamics significantly.
Furthermore, public health initiatives and educational campaigns have played a crucial role in enhancing awareness about parasitic diseases. The intertwining of animal health with human well-being underscores the necessity of antiparasitic interventions, reinforcing their critical position in Vietnam's healthcare framework.
Despite the promising growth, the Vietnam antiparasitics drugs market faces significant hurdles. One major constraint is the challenge of ensuring that antiparasitic medications remain effective, accessible, and affordable to the broader population. The prevalence of drug resistance amongst parasites complicates treatment protocols and necessitates ongoing research for new drug developments. Additionally, the public health infrastructure must be bolstered to effectively mitigate the widespread implications of parasitic infections. Comprehensive public health strategies, including awareness campaigns, are essential in addressing these issues while ensuring the sustained growth of the market.
A notable trend in the Vietnam antiparasitics drugs market is the increasing incorporation of advanced biotechnology into drug development. This shift is aimed at enhancing the efficacy and safety of antiparasitic treatments. Furthermore, there is a rising emphasis on integrated healthcare approaches that address both human and animal health, fostering collaborative efforts to tackle parasitic diseases. Digital health solutions, including telemedicine, are also becoming more prevalent, enabling better patient management and access to treatments.
Investment opportunities in the Vietnam antiparasitics drugs market are expanding, particularly in research and development initiatives aimed at combating drug resistance. Companies focusing on innovative delivery systems and combination therapies are poised to gain a competitive edge. Additionally, public-private partnerships can enhance healthcare outreach, facilitating broader access to antiparasitic treatments. As Vietnam strengthens its healthcare infrastructure post-pandemic, the focus on preventive health and disease management will further unlock potential growth avenues.
The Vietnamese government has demonstrated a strong commitment to tackling parasitic infections through various health programs and initiatives. Increased public spending on healthcare, including disease prevention and management, reflects a strategic approach to enhancing national health outcomes. Policies promoting accessibility of essential medicines and improving healthcare infrastructure are vital components of this strategy, further reinforcing the importance of antiparasitic drugs in the nation's health agenda.
Looking ahead, the Vietnam antiparasitics drugs market is likely to experience significant advancements driven by technological innovations and heightened public health consciousness. Between 2026 and 2032, a focus on sustainable practices in drug production and distribution will emerge as key to meeting the growing demand. As the market adapts to evolving healthcare needs, the integration of comprehensive health solutions that address both prevention and treatment will shape its future trajectory.
In recent months, the Vietnam antiparasitics drugs market has observed a series of strategic collaborations aimed at enhancing research capabilities and expanding the range of available treatments. Key stakeholders are increasingly focusing on addressing the challenges posed by drug resistance through collaborative research initiatives. Furthermore, there has been a notable increase in public awareness campaigns, aimed at educating citizens about the dangers of parasitic infections and the importance of prevention measures.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Antiparasitics Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Antiparasitics Drugs Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Vietnam Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Vietnam Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Vietnam Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2022 & 2032F |
3.7 Vietnam Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Vietnam Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Antiparasitics Drugs Market Trends |
6 Vietnam Antiparasitics Drugs Market, By Types |
6.1 Vietnam Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2022-2032F |
6.1.3 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Oral, 2022-2032F |
6.1.4 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2022-2032F |
6.1.5 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Topical, 2022-2032F |
6.2 Vietnam Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2022-2032F |
6.2.3 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2022-2032F |
6.2.4 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Others, 2022-2032F |
6.3 Vietnam Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.3.3 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.3.4 Vietnam Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Vietnam Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Antiparasitics Drugs Market Export to Major Countries |
7.2 Vietnam Antiparasitics Drugs Market Imports from Major Countries |
8 Vietnam Antiparasitics Drugs Market Key Performance Indicators |
9 Vietnam Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Vietnam Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Vietnam Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2022 & 2032F |
9.3 Vietnam Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Vietnam Antiparasitics Drugs Market - Competitive Landscape |
10.1 Vietnam Antiparasitics Drugs Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here